Embla Medical hf.
OSSFF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $2 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0% | 16.4% | -9.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.2% | 58.1% | 58.7% | 59.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 23.2% | 18.9% | 17% | 19.7% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 10.9% | 9% | 6% | 8.1% |
| EPS Diluted | 0.061 | 0.05 | 0.028 | 0.044 |
| % Growth | 21.2% | 78.6% | -36.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |